Tag Archive: Stemedica

Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

November 21, 2016 9:51 am Published by Comments Off on Clinical Trials for Alzheimer’s Disease (CTAD) Selects Stemedica International to Present at Annual International Conference

essay about child labour in india https://www.aestheticscienceinstitute.edu/news/cialis-stories/75/ pfizer viagra price increase free cialis in canada http://biointegrity.org/cheap-mexican-viagra/ https://www.crisiscenter.com/what-we-do/writing-a-university-essay/26/ http://www.salganyc.org/1688-make-online-pharmacy-viagra-yourself/ https://fall.law.fsu.edu/crc/?med=cost-for-viagra-100mg go to link https://www.flseagrant.org/news/bachelor-of-creative-writing-uq/29/ coupons for cialis viagra levitra viagra dosage yahoo viagra lead investigator essay experts arranged marriages essay viagra typical dosage comprar nexium dr 40 https://wisconsindailyindependent.com/best-site-to-buy-essays-2324/ professional writer services http://www.wellchild.org/prednisone-prescription/ buy cialis daily wuthering heights essay source site enter viagra dosage side effects viagra cialis canadian pharmacy buy viagra online from india source url San Diego, California and Lausanne, Switzerland — November 21, 2016 Stemedica International, SA, a leader in the development of innovative stem...
Read Entire Article

University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

November 1, 2016 5:55 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

IRVINE, CA — November 1, 2016 — Stemedica International, SA, a Stemedica Cell Technologies Inc. subsidiary that uses its proprietary...
Read Entire Article

University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

October 26, 2016 9:53 am Published by Comments Off on University of California Irvine (UCI) Doses First Patient in Phase IIa Clinical Trial Using Stemedica’s Stem Cells for Alzheimer’s disease

Lausanne, Switzerland — October 26, 2016 Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s...
Read Entire Article